Speakers

Adam Garske

Director - Protein Engineering

Mammoth Biosciences

Alexandria Petrusich

Vice President, Clinical Science

Prime Medicine

Anna Pugh

Scientist

Tune Therapeutics

Anubhav Arora

Director - Chemistry, Manufacturing & Controls

Apellis Pharmaceuticals

Ben Kleinstiver

Associate Professor Mass General Hospital

Harvard Medical School

Brad Ringeisen

Executive Director

Innovative Genomics Initiative

Carlo Zambonelli

Principal

Zambonelli Consulting

Chris Brown

Vice President - Discovery

Metagenomi

Dan Hart

Head of Technology Development

Epic Bio

Daniel Dornbusch

Chief Executive Officer

Excision BioTherapeutics Inc.

Eric Kmiec

Chief Executive Officer

CorriXR Therapeutics

Greg Newby

Assistant Professor

Johns Hopkins University

Kai-Yuan Chen

Director, Computational Genomics & Data Science

Scribe Therapeutics

Kiran Musunuru

Professor

University of Pennsylvania

Matteo Gentili

Senior Scientist

nChroma Bio

Max Sellman

Senior Product Manager, Gene Editing

Aldevron

Michael Sherman

Principal

Sherman Health Systems

NAGESWARA RAO KOLLU

Senior Director

Apellis Pharmaceuticals

Niren Murthy

Professor

University of California at Berkeley

Priya S. Chockalingam

Vice President, Head, Clinical Bioanalytics & Translational Sciences

Beam Therapeutics Inc.

Ralf Schmid

Associate Director - Preclinical Research

Novartis AG

Rammohan Devulapally

Director, Nonviral delivery

Independent Expert

Tetsuya Yamagata

Scientific Advisory, CSO

Modalis Therapeutics

TJ Cradick

Chief Technology Officer

Gene Editing Frontiers

Yi Yu

Senior Director- Platform Technologies